CLINICAL_TRIALS
trial_result
· 2023-03-23
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function [Phase 1]
Summary
A Phase 1 study evaluating tirzepatide (LY3298176) in participants with impaired kidney function has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Renal Insufficiency, End Stage Renal Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-03-23